Literature DB >> 26518279

Sonographic Detection of Extracapsular Extension in Papillary Thyroid Cancer.

Aya Kamaya1, Ali M Tahvildari2, Bhavik N Patel2, Juergen K Willmann2, R Brooke Jeffrey2, Terry S Desser2.   

Abstract

OBJECTIVES: To identify and evaluate sonographic features suggestive of extracapsular extension in papillary thyroid cancer.
METHODS: Three board-certified radiologists blinded to the final pathologic tumor stage reviewed sonograms of pathologically proven cases of papillary thyroid cancer for the presence of extracapsular extension. The radiologists evaluated the following features: capsular abutment, bulging of the normal thyroid contour, loss of the echogenic capsule, and vascularity extending beyond the capsule.
RESULTS: A total of 129 cases of pathologically proven thyroid cancer were identified. Of these, 51 were excluded because of lack of preoperative sonography, and 16 were excluded because of pathologic findings showing anaplastic carcinoma, follicular carcinoma, or microcarcinoma (<10 mm). The final analysis group consisted of 62 patients with papillary thyroid carcinoma, 16 of whom had pathologically proven extracapsular extension. The presence of capsular abutment had 100% sensitivity for detection of extracapsular extension. Conversely, lack of capsular abutment had a 100% negative predictive value (NPV) for excluding extracapsular extension. Contour bulging had 88% sensitivity for detection of extracapsular extension and when absent had an 87% NPV. Loss of the echogenic capsule was the best predictor of the presence of extracapsular extension, with an odds ratio of 10.23 (P = .034). This sonographic finding had 75% sensitivity, 65% specificity, and an 88% NPV. Vascularity beyond the capsule had 89% specificity but sensitivity of only 25%.
CONCLUSIONS: Sonographic features of capsular abutment, contour bulging, and loss of the echogenic thyroid capsule have excellent predictive value for excluding or detecting extracapsular extension and may help in biopsy selection, surgical planning, and treatment of patients with papillary thyroid cancer.
© 2015 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  capsular invasion; extracapsular extension; extrathyroidal extension; head and neck ultrasound; papillary thyroid cancer

Mesh:

Year:  2015        PMID: 26518279     DOI: 10.7863/ultra.15.02006

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  18 in total

1.  Toward Automated Pre-Biopsy Thyroid Cancer Risk Estimation in Ultrasound.

Authors:  Alfiia Galimzianova; Sean M Siebert; Aya Kamaya; Terry S Desser; Daniel L Rubin
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

2.  Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer.

Authors:  Yan Zhang; Xia Zhang; Jie Li; Qian Cai; Zhi Qiao; Yu Kun Luo
Journal:  Eur Radiol       Date:  2021-01-07       Impact factor: 5.315

Review 3.  Management of Invasive Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Ricard Simo; Kate Newbold; Alessandra Rinaldo; Carlos Suarez; Luiz P Kowalski; Carl Silver; Jatin P Shah; Alfio Ferlito
Journal:  Thyroid       Date:  2016-08-23       Impact factor: 6.568

4.  Is ultrasonographic evaluation sensitive enough to detect multicentric papillary thyroid carcinoma?

Authors:  Congqing Lu; Yan Wang; Ming Yu
Journal:  Gland Surg       Date:  2020-06

5.  Clinical study of ultrasonic evaluation of T/N staging of differentiated thyroid carcinoma using AJCC 8th staging criteria.

Authors:  Yu Liang; Xingxiang Huang; Zhe Song; Yang Yang; Ju Lei; Mei Ren; Li Tan; Hui Zhang
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

6.  The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma.

Authors:  Changlin Li; Haixia Guan; Qiao He; Yishen Zhao; Nan Liang; Jiao Zhang; Gianlorenzo Dionigi; Hui Sun
Journal:  Endocrine       Date:  2021-06-30       Impact factor: 3.633

7.  A meta-analysis of risk factors for lymph node posterior to the right recurrent laryngeal nerve metastasis in papillary thyroid carcinoma.

Authors:  Tianhan Zhou; Fan Wu; Lingqian Zhao; Kecheng Jiang; Dingcun Luo
Journal:  Gland Surg       Date:  2021-06

8.  miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.

Authors:  Zhenwei Qiu; Hai Li; Jianwei Wang; Chongbing Sun
Journal:  Oncol Rep       Date:  2017-09-25       Impact factor: 3.906

9.  Preoperative Factors Associated with Extrathyroidal Extension in Papillary Thyroid Cancer.

Authors:  Chi-Yu Kuo; Po-Sheng Yang; Ming-Nan Chien; Shih-Ping Cheng
Journal:  Eur Thyroid J       Date:  2020-04-14

10.  Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.

Authors:  Chan Yong Seong; Young Jun Chai; Sang Mok Lee; Su-Jin Kim; June Young Choi; Kyu Eun Lee; Ki-Tae Hwang; Sun-Won Park; Ka Hee Yi
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.